ONCO - Module 2 - Pegaspargenase

Name

Employee code

Mention your region (HQ of your RM)

CALLA is a biomarker for ALL. What does it stands for?

• Common acute lymphoblastic leukemia antigen

• Common acute lymphoid leukemia antigen

• Chronic and acute lymphoid antigen

• Commonly acquired lymphoblastic antigen

PegAspargenase suppress tumor growth by ___________

• Increasing protein biosynthesis

• Starving tumor cell of asparagine

• Blocking enzyme aspargenase

• None of the above

Pegaspargase is the only PEGylated asparaginase approved by both the FDA and the EMA.

• True

• Flase

Lyophilized Pegaspargase offers _____________.

• extended shelf life

• sustained bioavailability

• lower immunogenicity

• None of the above

Lyophilized Pegaspargase is a ________ formulation of liquid Pegaspargase

• recombinant

• pegylated

• freeze-dried

• injectible

Innovator brand of PegAspargenase is from _________

• Roche

• Cipla

• Servier

• Celon

Leukemia is divided into 2 distinct types: acute, which progresses quickly, and chronic, which progresses more slowly.

• True

• False